At the cellular level, the recognition of the albumin on the surface of NPs by cell receptors facilitates cellular uptake and increases their bioavailability, through specific receptors of tumor cells [16,17], and leads to higher NPs distribution in the tumor region by facilitating transcytosis across the endothelial barrier via the albumin receptor [17,18]. The gene discussed is ALB; the disease is neoplasm.